Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
| Current Price | ₹6,533.00 |
|---|---|
| Market Cap | ₹1,73,431 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 67.5 |
| Return on Equity | 16.19% |
| 52-Week Range | ₹5,636.50 – ₹7,071.50 |
| Beta (1Y) | 0.32 |
| Dividend Yield | 0.46% |
1. Active Pharmaceutical Ingredients, Intermediates and Nutraceutical Ingredients-100%
Divis Laboratories Limited is trading at ₹6,533.00, with a market capitalisation of ₹1,73,431 Cr.
Divis Laboratories Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Divis Laboratories Limited has a P/E of 67.5 and a return on equity of 16.19%.